HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Figures Only Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Buchert, R. Articles by Clausen, M. Search for Related Content PubMed PubMed Citation Articles by Buchert, R. Articles by Clausen, M.

Long-Term Effects of "Ecstasy" Use on Serotonin Transporters of the Brain Investigated by PET

¹ Department of Nuclear Medicine, University Hospital Hamburg-Eppendorf, Hamburg, Germany
² Department of Psychiatry and Psychotherapy, University Hospital Hamburg-Eppendorf, Hamburg, Germany

Alterations of the serotonergic system due to ecstasy consumption have been extensively documented in recent literature. However, reversibility of these neurotoxic effects still remains unclear. To address this question, PET was performed using the serotonin transporter (SERT) ligand ¹¹C-(+)-McN5652 in a total of 117 subjects subdivided into 4 groups: actual ecstasy users (n = 30), former ecstasy users (n = 29), drug-naive control subjects (n = 29), and subjects with abuse of psychoactive agents other than ecstasy (n = 29). Methods: About 500 MBq ¹¹C-(+)-McN5652 were injected intravenously. Thirty-five scans were acquired according to a dynamic scan protocol of 90 min using a full-ring whole-body PET system. Transaxial slices were reconstructed using an iterative method. Individual brains were transformed to a template defined earlier. Distribution volume ratios (DVRs) were derived by application of a reference tissue approach for reversible binding. Gray matter of the cerebellum served as reference. SERT-rich brain regions—mesencephalon, putamen, caudate, and thalamus—were selected for the evaluation of SERT availability using volumes of interest predefined in the template. Results: Compared with drug-naive control subjects, the DVR in actual ecstasy users was significantly reduced in the mesencephalon (P = 0.004) and the thalamus (P = 0.044). The DVR in former ecstasy users was very close to the DVR in drug-naive control subjects in all brain regions. The DVR in polydrug users was slightly higher than that in the drug-naive control subjects in all SERT-rich regions (not statistically significant). Conclusion: Our findings further support the hypothesis of ecstasy-induced protracted alterations of the SERT. In addition, they might indicate reversibility of the availability of SERT as measured by PET. However, this does not imply full reversibility of the neurotoxic effects.

Key Words: ecstasy • long-term effects • serotonin transporter • PET • ¹¹C-(+)-McN5652

This article has been cited by other articles:

				S. de Sola LLopis, M. Miguelez-Pan, J. Pena-Casanova, S. Poudevida, M. Farre, R. Pacifici, P. Bohm, S. Abanades, A. Verdejo Garcia, K. Langohr, et al. Cognitive performance in recreational ecstasy polydrug users: a two-year follow-up study J Psychopharmacol, July 1, 2008; 22(5): 498 - 510. [Abstract] [PDF]

				M. Slifstein Revisiting an Old Issue: The Discrepancy Between Tissue Ratio-Derived Binding Parameters and Kinetic Modeling-Derived Parameters After a Bolus of the Serotonin Transporter Radioligand 123I-ADAM J. Nucl. Med., February 1, 2008; 49(2): 176 - 178. [Full Text] [PDF]

				R. Buchert, F. Thiele, R. Thomasius, F. Wilke, K. Petersen, W. Brenner, J. Mester, L. Spies, and M. Clausen Ecstasy-induced reduction of the availability of the brain serotonin transporter as revealed by [11C](+)McN5652-PET and the multi-linear reference tissue model: loss of transporters or artifact of tracer kinetic modelling? J Psychopharmacol, August 1, 2007; 21(6): 628 - 634. [Abstract] [PDF]

				B. B. Quednow, F. Jessen, K.-U. Kuhn, W. Maier, I. Daum, and M. Wagner Memory deficits in abstinent MDMA (ecstasy) users: neuropsychological evidence of frontal dysfunction J Psychopharmacol, May 1, 2006; 20(3): 373 - 384. [Abstract] [PDF]

				C. Guillot and D. Greenway Recreational ecstasy use and depression J Psychopharmacol, May 1, 2006; 20(3): 411 - 416. [Abstract] [PDF]

				A. C. Parrott MDMA in humans: factors which affect the neuropsychobiological profiles of recreational ecstasy users, the integrative role of bioenergetic stress J Psychopharmacol, March 1, 2006; 20(2): 147 - 163. [Abstract] [PDF]

				N. Easton and C. A. Marsden Ecstasy: Are animal data consistent between species and can they translate to humans? J Psychopharmacol, March 1, 2006; 20(2): 194 - 210. [Abstract] [PDF]

				R. Thomasius, P. Zapletalova, K. Petersen, R. Buchert, B. Andresen, L. Wartberg, B. Nebeling, and A. Schmoldt Mood, cognition and serotonin transporter availability in current and former ecstasy (MDMA) users: the longitudinal perspective J Psychopharmacol, March 1, 2006; 20(2): 211 - 225. [Abstract] [PDF]

				R. Buchert, O. Schulze, F. Wilke, G. Berding, R. Thomasius, K. Petersen, W. Brenner, and M. Clausen Is Correction for Age Necessary in SPECT or PET of the Central Serotonin Transporter in Young, Healthy Adults? J. Nucl. Med., January 1, 2006; 47(1): 38 - 42. [Abstract] [Full Text] [PDF]

				A. Gamma, D. Brandeis, R. Brandeis, and F. X. Vollenweider The P3 in 'ecstasy' polydrug users during response inhibition and execution J Psychopharmacol, September 1, 2005; 19(5): 504 - 512. [Abstract] [PDF]

				W. G. Frankle, I. Lombardo, A. S. New, M. Goodman, P. S. Talbot, Y. Huang, D.-R. Hwang, M. Slifstein, S. Curry, A. Abi-Dargham, et al. Brain Serotonin Transporter Distribution in Subjects With Impulsive Aggressivity: A Positron Emission Study With [11C]McN 5652 Am J Psychiatry, May 1, 2005; 162(5): 915 - 923. [Abstract] [Full Text] [PDF]

				R. Buchert, R. Thomasius, F. Wilke, K. Petersen, B. Nebeling, J. Obrocki, O. Schulze, U. Schmidt, and M. Clausen A Voxel-Based PET Investigation of the Long-Term Effects of "Ecstasy" Consumption on Brain Serotonin Transporters Am J Psychiatry, July 1, 2004; 161(7): 1181 - 1189. [Abstract] [Full Text] [PDF]

				W. G. Frankle, Y. Huang, D.-R. Hwang, P. S. Talbot, M. Slifstein, R. Van Heertum, A. Abi-Dargham, and M. Laruelle Comparative Evaluation of Serotonin Transporter Radioligands 11C-DASB and 11C-McN 5652 in Healthy Humans J. Nucl. Med., April 1, 2004; 45(4): 682 - 694. [Abstract] [Full Text] [PDF]